
A person poses with a dose of Novavax Nuvaxovid COVID-19 vaccine in this illustration picture taken in Schwenksville, Pennsylvania, US October 2, 2025. — Reuters
PARIS: A vaccine targeting a broad range of viruses that was designed using artificial intelligence had a…

